As of 2025-06-19, the Relative Valuation of Eli Lilly and Co (LLY) is 245.62 USD. This relative valuation is based on P/E multiples. With the latest stock price at 785.03 USD, the upside of Eli Lilly and Co based on Relative Valuation is -68.7%.
The range of the Relative Valuation is 204.38 - 286.98 USD.
| Range | Selected | |
| Trailing P/E multiples | 17.4x - 23.6x | 19.3x |
| Forward P/E multiples | 18.5x - 21.6x | 20.0x |
| Fair Price | 204.38 - 286.98 | 245.62 |
| Upside | -74.0% - -63.4% | -68.7% |
| Date | P/E |
| 2025-06-17 | 67.52 |
| 2025-06-16 | 68.91 |
| 2025-06-13 | 69.92 |
| 2025-06-12 | 69.29 |
| 2025-06-11 | 69.00 |
| 2025-06-10 | 68.88 |
| 2025-06-09 | 66.02 |
| 2025-06-06 | 65.70 |
| 2025-06-05 | 65.34 |
| 2025-06-04 | 65.35 |
| 2025-06-03 | 64.07 |
| 2025-06-02 | 63.75 |
| 2025-05-30 | 62.95 |
| 2025-05-29 | 61.66 |
| 2025-05-28 | 61.39 |
| 2025-05-27 | 61.89 |
| 2025-05-23 | 60.90 |
| 2025-05-22 | 61.03 |
| 2025-05-21 | 61.86 |
| 2025-05-20 | 63.74 |
| 2025-05-19 | 64.44 |
| 2025-05-16 | 64.63 |
| 2025-05-15 | 62.57 |
| 2025-05-14 | 61.06 |
| 2025-05-13 | 63.66 |
| 2025-05-12 | 64.47 |
| 2025-05-09 | 62.68 |
| 2025-05-08 | 64.12 |
| 2025-05-07 | 66.28 |
| 2025-05-06 | 66.14 |
| 2025-05-05 | 70.10 |
| 2025-05-02 | 70.28 |
| 2025-05-01 | 67.76 |
| 2025-04-30 | 76.71 |
| 2025-04-29 | 75.54 |
| 2025-04-28 | 74.86 |
| 2025-04-25 | 75.48 |
| 2025-04-24 | 73.36 |
| 2025-04-23 | 70.78 |
| 2025-04-22 | 70.62 |
| 2025-04-21 | 69.80 |
| 2025-04-17 | 71.68 |
| 2025-04-16 | 62.71 |
| 2025-04-15 | 64.61 |
| 2025-04-14 | 64.37 |
| 2025-04-11 | 62.50 |
| 2025-04-10 | 61.52 |
| 2025-04-09 | 64.32 |
| 2025-04-08 | 61.97 |
| 2025-04-07 | 61.76 |